GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » Price-to-Operating-Cash-Flow

Amryt Pharma (Amryt Pharma) Price-to-Operating-Cash-Flow : 9.88 (As of May. 19, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma Price-to-Operating-Cash-Flow?

As of today (2024-05-19), Amryt Pharma's share price is $14.70. Amryt Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 was $1.49. Hence, Amryt Pharma's Price-to-Operating-Cash-Flow Ratio for today is 9.88.

The historical rank and industry rank for Amryt Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

AMYT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.56   Med: 16.09   Max: 79.14
Current: 9.88

During the past 12 years, Amryt Pharma's highest Price-to-Operating-Cash-Flow Ratio was 79.14. The lowest was 4.56. And the median was 16.09.

AMYT's Price-to-Operating-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 17.75 vs AMYT: 9.88

Amryt Pharma's Cash Flow from Operations per share for the three months ended in Sep. 2022 was $0.22. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 was $1.49.

During the past 12 years, Amryt Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was -27.90% per year. The lowest was -148.70% per year. And the median was -73.50% per year.


Amryt Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Amryt Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma Price-to-Operating-Cash-Flow Chart

Amryt Pharma Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 16.70 34.29

Amryt Pharma Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 34.29 33.89 - 4.65

Competitive Comparison of Amryt Pharma's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Amryt Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amryt Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amryt Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amryt Pharma's Price-to-Operating-Cash-Flow falls into.



Amryt Pharma Price-to-Operating-Cash-Flow Calculation

Amryt Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=14.70/1.488
=9.88

Amryt Pharma's Share Price of today is $14.70.
Amryt Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.49.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Amryt Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Amryt Pharma (Amryt Pharma) Business Description

Traded in Other Exchanges
N/A
Address
196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH
Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).

Amryt Pharma (Amryt Pharma) Headlines

From GuruFocus

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

By sperokesalga sperokesalga 04-12-2023

Amryt to Report Q2 2022 Results on August 4, 2022

By PurpleRose PurpleRose 07-21-2022